Creative leadership : mining the gold in your workforce / by 338429 Damiani, A. S. Migs

Mean cost per number needed to treat with tocilizumab plus methotrexate versus abatacept plus methotrexate in the treatment of rheumatoid arthritis in patients previously treated w... by Benucci M, Ravasio R, Damiani A

Get full text

Abatacept: from a budget impact model to cost-effectiveness analysis – data from RCT and real life by Benucci M, Damiani A, Manfredi M, Infantino M, Grossi V, Li Gobbi F

Get full text

Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data by Benucci M, Damiani A, Li Gobbi F, Grossi V, Infantino M, Manfredi M, Niccoli L, Cantini F

Get full text

Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseases by Benucci M, Damiani A, Li Gobbi F, Bandinelli F, Infantino M, Grossi V, Manfredi M, Noguier G, Meacci F

Get full text

Immunoglobulin A antibodies to oxidized collagen type II as a potential biomarker for the stratification of spondyloarthritis from rheumatoid arthritis by Vinci, C, Infantino, M, Raturi, S, Tindell, A, Topping, LM, Strollo, R, Amital, H, Shoenfeld, Y, Gertel, S, Grossi, V, Manfredi, M, Rutigliano, IM, Bandinelli, F, Li Gobbi, F, Damiani, A, Pozzilli, P, Mcinnes, IB, Goodyear, CS, Benucci, M, Nissim, A